Henry S. Park, MD, MPH

• Aarti Bhatia
• Abhijit Patel
• Ajay Malhotra
• Alessandro Santin
• Amit Mahajan
• Andrea Barbieri
• Anita Huttner
• Asher Marks
• Barbara Burtness
• Benjamin L. Judson
• Brian M. Shuch
• Bruce Haffty
• Cary Gross
• Christin A. Knowlton
• Christopher Tien
• Daniel Boffa
• David J. Carlson
• Elena Ratner
• Elizabeth H. Holt
• Francine Foss
• Frank Detterbeck
• Gang Peng
• Gloria Huang
• Hari Deshpande
• Harlan Krumholz
• Harriet Kluger
• Harry Subramanian
• Hongyu Zhao
• James Clune
• James E. Hansen
• Jeffrey Weinreb
• Jeremy Kortmansky
• Jill Lacy
• Joachim Baehring
• Joseph Miccio
• Joseph N. Contessa
• Justin D. Blasberg
• Kelly Olino
• Kenneth B. Roberts
• Kerin Adelson
• Kimberly L. Johung
• Leah Ferrucci
• Lynn D. Wilson
• Masoud Azodi
• Maxwell Laurans
• Meena S. Moran
• Melinda Irwin
• Melissa Young
• Michael Cecchini
• Michael DiLuna
• Michael Girardi
• Michael S. Leapman
• Michaela Dinan
• Morgan Levine
• Patricia Peter
• Preston C. Sprenkle
• Ranjit S. Bindra
• Rohan Khera
• Ronald Salem
• Rong Wang
• Roy H. Decker
• Sacit Bulent Omay
• Sajid A Khan
• Sam Payabvash
• Sanjay Aneja
• Sarah Goldberg
• Saral Mehra
• Shari Damast
• Shuangge Steven Ma
• Stacey Stein
• Susan A. Higgins
• Suzanne B. Evans
• Ted Melnick
• Thomas Hayman
• Veronica Chiang
• Vikram Jairam
• Wesley Talcott
• Xiaomei Ma
• Yi An
• Yung H. Son
• Zhe Jay Chen
• Zuoheng Anita Wang

Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Lung Neoplasms; Radiation; Small Cell Lung Carcinoma; Mentoring

• Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty?Park HS, Roman SA, Sosa JA. Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Archives Of Surgery (Chicago, Ill. : 1960) 2009, 144: 1060-7. PMID: 19917944, DOI: 10.1001/archsurg.2009.191.
• Treatment patterns of aging Americans with differentiated thyroid cancer.Park HS, Roman SA, Sosa JA. Treatment patterns of aging Americans with differentiated thyroid cancer. Cancer 2010, 116: 20-30. PMID: 19908255, DOI: 10.1002/cncr.24717.
• Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update.Park HS, Chiang VL, Knisely JP, Raldow AC, Yu JB. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Review Of Anticancer Therapy 2011, 11: 1731-8. PMID: 22050022, DOI: 10.1586/era.11.165.
• Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes. Current Problems In Cancer 2012, 36: 191-9. PMID: 22495057, DOI: 10.1016/j.currproblcancer.2012.03.008.
• Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?Yu JB, Lloyd S, Decker RH, Wilson LD, Park HS. Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important? Current Problems In Cancer 2012, 36: 208-15. PMID: 22481005, DOI: 10.1016/j.currproblcancer.2012.03.010.
• Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance.Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Current Problems In Cancer 2012, 36: 183-90. PMID: 22481006, DOI: 10.1016/j.currproblcancer.2012.03.007.
• Prediction models, nomograms, and staging validation with the Surveillance, Epidemiology, and End Results database: using Surveillance, Epidemiology and End Results (SEER) program to create prediction models.Lloyd S, Park HS, Wilson LD, Decker RH, Yu JB. Prediction models, nomograms, and staging validation with the Surveillance, Epidemiology, and End Results database: using Surveillance, Epidemiology and End Results (SEER) program to create prediction models. Current Problems In Cancer 2012, 36: 200-7. PMID: 22481008, DOI: 10.1016/j.currproblcancer.2012.03.009.
• Limitations and biases of the Surveillance, Epidemiology, and End Results database.Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and biases of the Surveillance, Epidemiology, and End Results database. Current Problems In Cancer 2012, 36: 216-24. PMID: 22481009, DOI: 10.1016/j.currproblcancer.2012.03.011.
• Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes.Park HS, Detterbeck FC, Boffa DJ, Kim AW. Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. The Annals Of Thoracic Surgery 2012, 93: 372-9. PMID: 21945225, DOI: 10.1016/j.athoracsur.2011.06.054.
• Delayed radiation-induced vasculitic leukoencephalopathy.Rauch PJ, Park HS, Knisely JP, Chiang VL, Vortmeyer AO. Delayed radiation-induced vasculitic leukoencephalopathy. International Journal Of Radiation Oncology, Biology, Physics 2012, 83: 369-75. PMID: 22024206, DOI: 10.1016/j.ijrobp.2011.06.1982.
• Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.Buscariollo DL, Park HS, Roberts KB, Yu JB. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 2012, 118: 4212-9. PMID: 22213196, DOI: 10.1002/cncr.27373.
• Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy.Park HS, Gross CP, Makarov DV, Yu JB. Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. International Journal Of Radiation Oncology, Biology, Physics 2012, 83: 1365-73. PMID: 22342097, DOI: 10.1016/j.ijrobp.2011.10.025.
• Lethality of cardiovascular events highlights the variable impact of complication type between thoracoscopic and open pulmonary lobectomies.Law TD, Boffa DJ, Detterbeck FC, Wang Z, Park HS, Kim AW. Lethality of cardiovascular events highlights the variable impact of complication type between thoracoscopic and open pulmonary lobectomies. The Annals Of Thoracic Surgery 2014, 97: 993-9. PMID: 24370204, DOI: 10.1016/j.athoracsur.2013.10.026.
• Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States.Rutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States. Lung Cancer (Amsterdam, Netherlands) 2014, 85: 390-4. PMID: 25001510, DOI: 10.1016/j.lungcan.2014.06.013.
• Racial disparities in the use of SBRT for treating early-stage lung cancer.Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of SBRT for treating early-stage lung cancer. Lung Cancer (Amsterdam, Netherlands) 2015, 89: 133-8. PMID: 26051446, DOI: 10.1016/j.lungcan.2015.05.002.
• Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Practical Radiation Oncology 2015, 5: e643-9. PMID: 26412341, DOI: 10.1016/j.prro.2015.07.003.
• Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2015, 33: 2727-34. PMID: 26101240, DOI: 10.1200/JCO.2015.61.1517.
• Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer.Park HS, Harder EM, Mancini BR, Decker RH. Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2015, 10: 832-837. PMID: 25634007, DOI: 10.1097/JTO.0000000000000484.
• The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer.Rutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer 2015, 121: 2331-40. PMID: 25810128, DOI: 10.1002/cncr.29377.
• Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.Park HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Clinical Lung Cancer 2015, 16: 292-7. PMID: 25499149, DOI: 10.1016/j.cllc.2014.11.005.
• Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Lung Cancer (Amsterdam, Netherlands) 2015, 90: 243-8. PMID: 26277031, DOI: 10.1016/j.lungcan.2015.08.002.
• Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States.Rutter CE, Yu JB, Wilson LD, Park HS. Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States. International Journal Of Radiation Oncology, Biology, Physics 2015, 91: 548-55. PMID: 25542310, DOI: 10.1016/j.ijrobp.2014.10.045.
• Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.Corso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, Husain ZA, Lilenbaum RC, Yu JB, Decker RH. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2015, 33: 4240-6. PMID: 26481366, PMCID: PMC4678178, DOI: 10.1200/JCO.2015.62.4270.
• Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.Wang EH, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park HS. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2015, 10: 937-43. PMID: 25738221, DOI: 10.1097/JTO.0000000000000519.
• Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.Park HS, Ratner ES, Lucarelli L, Polizzi S, Higgins SA, Damast S. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma. Brachytherapy 2015, 14: 464-70. PMID: 25887343, DOI: 10.1016/j.brachy.2015.03.001.
• Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 2015, 121: 4141-9. PMID: 26280559, DOI: 10.1002/cncr.29652.
• Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.Rutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States. Annals Of Surgical Oncology 2015, 22: 2378-86. PMID: 25564175, DOI: 10.1245/s10434-014-4334-x.
• Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PloS One 2015, 10: e0122488. PMID: 25875167, PMCID: PMC4396854, DOI: 10.1371/journal.pone.0122488.
• Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients.Stahl JM, Park HS, Silasi DA, Azodi M, Damast S. Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients. Practical Radiation Oncology 2016, 6: 226-232. PMID: 27364883, DOI: 10.1016/j.prro.2015.09.015.
• The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer.Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Urology 2016, 96: 128-135. PMID: 27392652, DOI: 10.1016/j.urology.2016.06.042.
• Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.Mancini BR, Park HS, Harder EM, Rutter CE, Corso CD, Decker RH, Husain ZA. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients. Lung Cancer (Amsterdam, Netherlands) 2016, 97: 22-7. PMID: 27237023, DOI: 10.1016/j.lungcan.2016.04.011.
• Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. Journal Of Neurosurgery 2016, 124: 1018-24. PMID: 26473783, DOI: 10.3171/2015.4.JNS1573.
• Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base. Gynecologic Oncology 2016, 142: 54-61. PMID: 27151429, DOI: 10.1016/j.ygyno.2016.04.544.
• Author Reply.Lester-Coll NH, Park HS, Gross CP, Yu JB. Author Reply. Urology 2016, 96: 134-135. PMID: 27492667, DOI: 10.1016/j.urology.2016.06.044.
• Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer 2016, 122: 2364-70. PMID: 27172136, DOI: 10.1002/cncr.30063.
• Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Practical Radiation Oncology 2016, 6: e353-e359. PMID: 27156424, DOI: 10.1016/j.prro.2016.01.015.
• Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases.Colaco RJ, Park HS, Laurans MS, Chiang VS, Yu JB, Husain ZA. Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases. Cure¯us 2016, 8: e679. PMID: 27563505, PMCID: PMC4985044, DOI: 10.7759/cureus.679.
• Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children.Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
• Adjuvant hypofractionated partial-brain radiation therapy for pediatric Ewing sarcoma brain metastases: case report.van Dams R, Park HS, Alomari AK, Ricciardi AS, Rao H, McNamara J, DiLuna ML, Bindra RS. Adjuvant hypofractionated partial-brain radiation therapy for pediatric Ewing sarcoma brain metastases: case report. Journal Of Neurosurgery. Pediatrics 2016, 17: 434-8. PMID: 26636250, DOI: 10.3171/2015.8.PEDS15313.
• In Regard to Vaidya et al.Park HS, Ma S, Wilson LD, Moran MS. In Regard to Vaidya et al. International Journal Of Radiation Oncology, Biology, Physics 2016, 96: 706-7. PMID: 27681768, DOI: 10.1016/j.ijrobp.2016.06.2460.
• Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer.Park HS, Decker RH. Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer. Cancers Of The Head & Neck 2016, 1: 5. PMID: 31093335, PMCID: PMC6457146, DOI: 10.1186/s41199-016-0005-x.
• Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study.Subramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study. Cancers Of The Head & Neck 2016, 1: 7. PMID: 31093337, PMCID: PMC6460847, DOI: 10.1186/s41199-016-0008-7.
• Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy.Wang EH, Park HS, Rutter CE, Gross CP, Soulos PR, Yu JB, Evans SB. Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy. Cancer 2017, 123: 502-511. PMID: 27657353, DOI: 10.1002/cncr.30356.
• Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity.Gao SJ, Park HS, Corso CD, Rutter CE, Kim AW, Johung KL. Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity. The Annals Of Thoracic Surgery 2017, 104: 267-274. PMID: 28456393, DOI: 10.1016/j.athoracsur.2017.01.092.
• Response.Tchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Response. Chest 2017, 151: 942-943. PMID: 28390633, DOI: 10.1016/j.chest.2017.01.017.
• Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas.Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiotherapy And Oncology : Journal Of The European Society For Therapeutic Radiology And Oncology 2017, 125: 258-265. PMID: 29054377, DOI: 10.1016/j.radonc.2017.09.027.
• Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States.Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB. Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. Journal Of The National Comprehensive Cancer Network : JNCCN 2017, 15: 1494-1502. PMID: 29223987, DOI: 10.6004/jnccn.2017.7003.
• Adjuvant chemotherapy and overall survival in adult medulloblastoma.Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro-oncology 2017, 19: 259-269. PMID: 27540083, PMCID: PMC5464064, DOI: 10.1093/neuonc/now150.
• Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer. Journal Of The National Comprehensive Cancer Network : JNCCN 2017, 15: 355-362. PMID: 28275036, DOI: 10.6004/jnccn.2017.0035.
• Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.Lester-Coll NH, Young MR, Park HS, Ratner ES, Litkouhi B, Damast S. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer. International Journal Of Gynecological Cancer : Official Journal Of The International Gynecological Cancer Society 2017, 27: 1904-1911. PMID: 28763364, DOI: 10.1097/IGC.0000000000001095.
• The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer 2017, 123: 2762-2772. PMID: 28323338, DOI: 10.1002/cncr.30598.
• Hospital Volume and Outcomes of Robot-Assisted Lobectomies.Tchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Hospital Volume and Outcomes of Robot-Assisted Lobectomies. Chest 2017, 151: 329-339. PMID: 27687847, DOI: 10.1016/j.chest.2016.09.008.
• A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. JAMA Oncology 2017, 3: 358-365. PMID: 27737449, DOI: 10.1001/jamaoncol.2016.4581.
• The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.Lee NCJ, Kelly JR, Park HS, Yarbrough WG, Burtness BA, Husain ZA. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation. Practical Radiation Oncology 2017, 7: e317-e321. PMID: 28356201, DOI: 10.1016/j.prro.2017.02.004.
• Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome.Kann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clinical Lymphoma, Myeloma & Leukemia 2017, 17: 520-526.e2. PMID: 28655598, DOI: 10.1016/j.clml.2017.05.017.
• Trends in stereotactic body radiation therapy for stage I small cell lung cancer.Stahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB, Kim AW, Decker RH. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 2017, 103: 11-16. PMID: 28024690, DOI: 10.1016/j.lungcan.2016.11.009.
• Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins.Gao SJ, Park HS, Corso CD, Rutter CE, Khan SA, Johung KL. Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins. Journal Of Gastrointestinal Oncology 2017, 8: 953-961. PMID: 29299354, PMCID: PMC5750177, DOI: 10.21037/jgo.2017.08.12.
• Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. JAMA Oncology 2017, 3: 1107-1111. PMID: 28056116, PMCID: PMC5824218, DOI: 10.1001/jamaoncol.2016.5769.
• Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival. Journal Of The National Cancer Institute 2017, 109 PMID: 28521361, DOI: 10.1093/jnci/djx042.
• Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings.Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Practical Radiation Oncology 2018, 8: e79-e86. PMID: 28888675, DOI: 10.1016/j.prro.2017.07.005.
• Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, Abrams RA, Shu HG, Curran WJ, Crocker IR, Patel KR. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. Journal Of Neuro-oncology 2018, 136: 289-298. PMID: 29124649, PMCID: PMC5784434, DOI: 10.1007/s11060-017-2652-0.
• Response.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Response. Journal Of The National Cancer Institute 2018, 110: 433-434. PMID: 29121329, DOI: 10.1093/jnci/djx230.
• Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer. American Journal Of Clinical Oncology 2018, 41: 152-158. PMID: 26523443, DOI: 10.1097/COC.0000000000000245.
• Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base. Cancer 2018, 124: 717-726. PMID: 29243245, DOI: 10.1002/cncr.31104.
• Use of Alternative Medicine for Cancer and Its Impact on Survival.Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. Journal Of The National Cancer Institute 2018, 110 PMID: 28922780, DOI: 10.1093/jnci/djx145.
• Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology 2018, 79: 64-70. PMID: 29598952, DOI: 10.1016/j.oraloncology.2018.02.017.
• Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer.Breen W, Kelly J, Park HS, Son Y, Sasaki C, Wilson L, Decker R, Husain ZA. Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer. Cure¯us 2018, 10: e2517. PMID: 29942720, PMCID: PMC6015992, DOI: 10.7759/cureus.2517.
• Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.Johnson SB, Park HS, Gross CP, Yu JB. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. JAMA Oncology 2018, 4: 1375-1381. PMID: 30027204, PMCID: PMC6233773, DOI: 10.1001/jamaoncol.2018.2487.
• Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.Lee NCJ, Kelly JR, Park HS, An Y, Judson BL, Burtness BA, Husain ZA. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma. Oral Oncology 2018, 85: 35-39. PMID: 30220317, DOI: 10.1016/j.oraloncology.2018.08.001.
• Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks.Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks. Scientific Reports 2018, 8: 14036. PMID: 30232350, PMCID: PMC6145900, DOI: 10.1038/s41598-018-32441-y.
• Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR. Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database. Frontiers In Oncology 2018, 8: 678. PMID: 30693271, PMCID: PMC6339938, DOI: 10.3389/fonc.2018.00678.
• Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas.Li H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Of The Head & Neck 2018, 3: 4. PMID: 31093357, PMCID: PMC6460664, DOI: 10.1186/s41199-018-0031-y.
• Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer.Leapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer. Urology 2019, 124: 98-106. PMID: 30107188, DOI: 10.1016/j.urology.2018.07.041.
• Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.Cheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma. The Laryngoscope 2019, 129: 883-889. PMID: 30151947, DOI: 10.1002/lary.27444.
• Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.Stahl JM, Qian JM, Tien CJ, Carlson DJ, Chen Z, Ratner ES, Park HS, Damast S. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. Supportive Care In Cancer : Official Journal Of The Multinational Association Of Supportive Care In Cancer 2019, 27: 1425-1433. PMID: 30187220, DOI: 10.1007/s00520-018-4441-5.
• Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.Kann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis. Radiotherapy And Oncology : Journal Of The European Society For Therapeutic Radiology And Oncology 2019, 132: 188-196. PMID: 30391106, DOI: 10.1016/j.radonc.2018.10.017.
• Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.Li H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption. The Laryngoscope 2019, 129: 1844-1855. PMID: 30575965, DOI: 10.1002/lary.27740.
• Suicide among cancer patients.Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Suicide among cancer patients. Nature Communications 2019, 10: 207. PMID: 30643135, PMCID: PMC6331593, DOI: 10.1038/s41467-018-08170-1.
• AUTHOR REPLY.Leapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. AUTHOR REPLY. Urology 2019, 124: 106. PMID: 30784707, DOI: 10.1016/j.urology.2018.07.043.
• Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.Lee NCJ, Kelly JR, An Y, Park HS, Judson BL, Burtness BA, Husain ZA. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma. Cancer 2019, 125: 2018-2026. PMID: 30748002, PMCID: PMC6541535, DOI: 10.1002/cncr.32001.
• Treatment-Related Complications of Systemic Therapy and Radiotherapy.Jairam V, Lee V, Park HS, Thomas CR, Melnick ER, Gross CP, Presley CJ, Adelson KB, Yu JB. Treatment-Related Complications of Systemic Therapy and Radiotherapy. JAMA Oncology 2019, 5: 1028-1035. PMID: 30946433, PMCID: PMC6583836, DOI: 10.1001/jamaoncol.2019.0086.
• Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.Kann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, Gross CP, Park HS, Yu JB, Decker RH. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiotherapy And Oncology : Journal Of The European Society For Therapeutic Radiology And Oncology 2019, 134: 44-49. PMID: 31005223, DOI: 10.1016/j.radonc.2019.01.027.
• Quality at the American Society for Radiation Oncology Annual Meeting: Gender Balance Among Invited Speakers and Associations with Panel Success.Rahimy E, Jagsi R, Park HS, Moran JM, Cervino L, Albert A, Lee A, Evans S. Quality at the American Society for Radiation Oncology Annual Meeting: Gender Balance Among Invited Speakers and Associations with Panel Success. International Journal Of Radiation Oncology, Biology, Physics 2019, 104: 987-996. PMID: 31085284, DOI: 10.1016/j.ijrobp.2019.05.005.
• Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment.Lee NCJ, Eskander A, Park HS, Mehra S, Burtness BA, Husain Z. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Cancer 2019, 125: 2975-2983. PMID: 31090934, DOI: 10.1002/cncr.32161.
• Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.Jairam V, Kann BH, Park HS, Miccio JA, Beckta JM, Yu JB, Prabhu RS, Gao SJ, Mehta MP, Curran WJ, Bindra RS, Contessa JN, Patel KR. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis. Anticancer Research 2019, 39: 2911-2918. PMID: 31177129, DOI: 10.21873/anticanres.13420.
• Overall survival is improved when DCIS accompanies invasive breast cancer.Kole AJ, Park HS, Johnson SB, Kelly JR, Moran MS, Patel AA. Overall survival is improved when DCIS accompanies invasive breast cancer. Scientific Reports 2019, 9: 9934. PMID: 31289308, PMCID: PMC6616329, DOI: 10.1038/s41598-019-46309-2.
• Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related Products.Jairam V, Lincoln H, Brown D, Park HS, Evans SB. Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related Products. Practical Radiation Oncology 2020, 10: e8-e15. PMID: 31408733, DOI: 10.1016/j.prro.2019.08.001.
• Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.Loganadane G, Kann BH, Park HS, Johnson SB, Mehra S, Judson BL, Bhatia A, Belkacemi Y, Yarbrough WG, Burtness B, Husain ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research 2019, 39: 4885-4890. PMID: 31519591, DOI: 10.21873/anticanres.13674.
• The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.Stahl JM, Corso CD, Park HS, An Y, Rutter CE, Han D, Roberts KB. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. European Journal Of Surgical Oncology : The Journal Of The European Society Of Surgical Oncology And The British Association Of Surgical Oncology 2017, 43: 168-174. PMID: 27335080, DOI: 10.1016/j.ejso.2016.05.031.
• Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition.Miccio JA, Verma V, Kelly J, Kann BH, An Y, Park HS, Eskander A, Burtness B, Husain Z. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition. Oral Oncology 2019, 99: 104447. PMID: 31630059, DOI: 10.1016/j.oraloncology.2019.104447.
• Strengths and limitations of large databases in lung cancer radiation oncology research.Jairam V, Park HS. Strengths and limitations of large databases in lung cancer radiation oncology research. Translational Lung Cancer Research 2019, 8: S172-S183. PMID: 31673522, PMCID: PMC6795574, DOI: 10.21037/tlcr.2019.05.06.
• Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial Disease.Pourghaderi P, Yuquimpo KM, Roginski Guetter C, Mansfield L, Park HS. Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial Disease. Annals Of Vascular Surgery 2020, 63: 259-268. PMID: 31626926, DOI: 10.1016/j.avsg.2019.08.084.
• Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.Kann BH, Hicks DF, Payabvash S, Mahajan A, Du J, Gupta V, Park HS, Yu JB, Yarbrough WG, Burtness BA, Husain ZA, Aneja S. Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2020, 38: 1304-1311. PMID: 31815574, DOI: 10.1200/JCO.19.02031.
• Emergency Department Visits for Opioid Overdoses Among Patients With Cancer.Jairam V, Yang DX, Yu JB, Park HS. Emergency Department Visits for Opioid Overdoses Among Patients With Cancer. Journal Of The National Cancer Institute 2020, 112: 938-943. PMID: 31845985, PMCID: PMC7492769, DOI: 10.1093/jnci/djz233.
• Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use?Park HS, Yu JB. Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use? JAMA Oncology 2020, 6: 246-247. PMID: 31876903, DOI: 10.1001/jamaoncol.2019.4875.
• Cancer Clinical Trial Enrollment: OK Doc, but What's in It for Me?Park HS. Cancer Clinical Trial Enrollment: OK Doc, but What's in It for Me? Journal Of The National Comprehensive Cancer Network : JNCCN 2019, 17: 1404-1405. PMID: 31693990, DOI: 10.6004/jnccn.2019.7365.
• Author Correction: Suicide among cancer patients.Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Author Correction: Suicide among cancer patients. Nature Communications 2020, 11: 718. PMID: 32005824, PMCID: PMC6994458, DOI: 10.1038/s41467-020-14506-7.
• Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer.Saeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.
• Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.Jairam V, Park HS, Decker RH. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. Cancer Journal (Sudbury, Mass.) 2020, 26: 129-136. PMID: 32205537, DOI: 10.1097/PPO.0000000000000433.
• Mentorship in Radiation Oncology: Role of Gender Diversity in Abstract Presenting and Senior Author Dyads on Subsequent High-Impact Publications.Lee A, Albert A, Griffith K, Evans S, Rahimy E, Park HS, Cervino LI, Moran JM, Jagsi R. Mentorship in Radiation Oncology: Role of Gender Diversity in Abstract Presenting and Senior Author Dyads on Subsequent High-Impact Publications. Advances In Radiation Oncology 2020, 5: 292-296. PMID: 32280830, PMCID: PMC7136636, DOI: 10.1016/j.adro.2019.10.005.
• National trends in the management of patients with positive surgical margins at radical prostatectomy.Ghabili K, Park HS, Yu JB, Sprenkle PC, Kim SP, Nguyen KA, Ma X, Gross CP, Leapman MS. National trends in the management of patients with positive surgical margins at radical prostatectomy. World Journal Of Urology 2021, 39: 1141-1151. PMID: 32562045, DOI: 10.1007/s00345-020-03298-6.
• Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation.Lee V, Jairam V, Yu JB, Park HS. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation. Scientific Reports 2020, 10: 10084. PMID: 32572113, PMCID: PMC7308286, DOI: 10.1038/s41598-020-67316-8.
• Resident attitudes and benefits of mock oral board examinations in radiation oncology.Peters GW, Decker RH, Park HS, Yu JB, Evans SB. Resident attitudes and benefits of mock oral board examinations in radiation oncology. BMC Medical Education 2020, 20: 203. PMID: 32586357, PMCID: PMC7318518, DOI: 10.1186/s12909-020-02106-4.
• Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.Harder EM, Chen ZJ, Park HS, Mancini BR, Decker RH. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy. American Journal Of Clinical Oncology 2017, 40: 477-482. PMID: 26017483, DOI: 10.1097/COC.0000000000000195.
• Stage I Lung SBRT Clinical Practice Patterns.Corso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT Clinical Practice Patterns. American Journal Of Clinical Oncology 2017, 40: 358-361. PMID: 25503436, DOI: 10.1097/COC.0000000000000162.
• Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States.J Bledsoe T, S Park H, E Rutter C, Aneja S, Nguyen PL, B Yu J. Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States. American Journal Of Clinical Oncology 2018, 41: 1062-1068. PMID: 29521648, DOI: 10.1097/COC.0000000000000423.
• Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2013, 24: 1427-34. PMID: 23508824, PMCID: PMC3660083, DOI: 10.1093/annonc/mdt077.
• Reply to 'Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer' by T. Kawada.Park H, Schoenfeld J, Mucci L. Reply to 'Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer' by T. Kawada. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2014, 25: 543-4. PMID: 24419238, DOI: 10.1093/annonc/mdt565.
• Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases.Jairam V, Lee V, Yu JB, Park HS. Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases. American Journal Of Clinical Oncology 2020, 43: 720-726. PMID: 32694296, DOI: 10.1097/COC.0000000000000737.
• Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population.Jairam V, Yang DX, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS. Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population. Journal Of The National Cancer Institute 2021, 113: 274-281. PMID: 32785685, PMCID: PMC7936059, DOI: 10.1093/jnci/djaa110.
• Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy.Miccio JA, Barsky A, Gao S, Verma V, Noticewala SS, Jairam V, Johnson SB, Yu JB, Hansen JE, Aneja S, An Y, Decker RH, Bulent Omay S, Li J, Kurtz GA, Alonso-Basanta M, Lee JYK, Chiang VL, Park HS. Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy. Journal Of Radiosurgery And SBRT 2020, 7: 19-27. PMID: 32802575, PMCID: PMC7406345.
• National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States.Jairam V, Yang DX, Verma V, Yu JB, Park HS. National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States. JAMA Network Open 2020, 3: e2013605. PMID: 32804217, PMCID: PMC7431994, DOI: 10.1001/jamanetworkopen.2020.13605.
• Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients.Miccio JA, Talcott WJ, Jairam V, Park HS, Yu JB, Leapman MS, Johnson SB, King MT, Nguyen PL, Kann BH. Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients. Prostate Cancer And Prostatic Diseases 2021, 24: 414-422. PMID: 32989262, DOI: 10.1038/s41391-020-00291-3.
• Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck.Jacobs D, Olino K, Park HS, Clune J, Cheraghlou S, Girardi M, Burtness B, Kluger H, Judson BL. Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck. Otolaryngology--head And Neck Surgery : Official Journal Of American Academy Of Otolaryngology-Head And Neck Surgery 2021, 164: 1214-1221. PMID: 33079010, DOI: 10.1177/0194599820967001.
• Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials.Pathak R, De Lima Lopes G, Yu H, Aryal MR, Ji W, Frumento KS, Wallis CJD, Klaassen Z, Park HS, Goldberg SB. Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials. Cancer 2021, 127: 709-719. PMID: 33119177, DOI: 10.1002/cncr.33269.
• Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer.Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer. Otolaryngology--head And Neck Surgery : Official Journal Of American Academy Of Otolaryngology-Head And Neck Surgery 2021, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
• Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy.Yang DX, Verma V, An Y, Yu JB, Sprenkle PC, Leapman MS, Park HS. Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy. Advances In Radiation Oncology 2020, 5: 1225-1231. PMID: 33305083, PMCID: PMC7718530, DOI: 10.1016/j.adro.2020.08.015.
• Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis.Miccio JA, Talcott WJ, Patel T, Park HS, Cecchini M, Salem RR, Khan SA, Stein S, Kortmansky JS, Lacy J, Narang A, Herman J, Jabbour SK, Hallemeier CL, Johung K, Jethwa KR. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis. Clinical And Translational Radiation Oncology 2021, 27: 15-23. PMID: 33392398, PMCID: PMC7772693, DOI: 10.1016/j.ctro.2020.12.003.
• Emergency Department Visits for Firearm-Related Injuries among Youth in the United States, 2006-2015.Lee V, Camp C, Jairam V, Park HS, Yu JB. Emergency Department Visits for Firearm-Related Injuries among Youth in the United States, 2006-2015. The Journal Of Law, Medicine & Ethics : A Journal Of The American Society Of Law, Medicine & Ethics 2020, 48: 67-73. PMID: 33404319, DOI: 10.1177/1073110520979403.
• Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system.Lee NCJ, Eskander A, Miccio JA, Park HS, Shah C, Rutenberg M, Hosni A, Husain ZA. Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system. Oral Oncology 2021, 114: 105137. PMID: 33422859, DOI: 10.1016/j.oraloncology.2020.105137.
• Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer.He Y, Song L, Wang H, Chen P, Liu Y, Sun H, Li X, Dang S, Liu G, Liu X, Chen S, Zhang X, Hofman P, Uchino J, Park HS, Pacheco JM, Tabbò F, Xu M, Dai J, He K, Yang Y, Zhou C. Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer. Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 2021, 8: 2003263. PMID: 33643802, PMCID: PMC7887584, DOI: 10.1002/advs.202003263.
• Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival.Yang DX, Khera R, Miccio JA, Jairam V, Chang E, Yu JB, Park HS, Krumholz HM, Aneja S. Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival. JAMA Network Open 2021, 4: e211793. PMID: 33755165, PMCID: PMC7988369, DOI: 10.1001/jamanetworkopen.2021.1793.
• Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma.Hong CS, Partovi E, Clune J, Huttner A, Park HS, Omay SB. Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma. Case Reports In Genetics 2021, 2021: 5586072. PMID: 33747576, PMCID: PMC7960067, DOI: 10.1155/2021/5586072.
• Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer.Xiao C, Miller AH, Peng G, Levine ME, Conneely KN, Zhao H, Eldridge RC, Wommack EC, Jeon S, Higgins KA, Shin DM, Saba NF, Smith AK, Burtness B, Park HS, Irwin ML, Ferrucci LM, Ulrich B, Qian DC, Beitler JJ, Bruner DW. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer. International Journal Of Radiation Oncology, Biology, Physics 2021, 111: 157-167. PMID: 33882281, PMCID: PMC8802868, DOI: 10.1016/j.ijrobp.2021.04.002.
• Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis.Diamond BH, Jairam V, Zuberi S, Li JY, Marquis TJ, Rutter CE, Park HS. Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis. Journal Of Radiosurgery And SBRT 2021, 7: 179-187. PMID: 33898081, PMCID: PMC8055233.
• The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer.Hsiang W, Han X, Jemal A, Nguyen KA, Shuch B, Park H, Yu JB, Gross CP, Davidoff AJ, Leapman MS. The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer. Urology Practice 2020, 7: 252-258. PMID: 34017908, PMCID: PMC8130174, DOI: 10.1097/upj.0000000000000109.
• Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here?Park HS. Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here? Journal Of The National Comprehensive Cancer Network : JNCCN 2021, 19: 577-579. PMID: 34030129, DOI: 10.6004/jnccn.2021.7045.
• Social Connectedness Among Medicare Beneficiaries Following the Onset of the COVID-19 Pandemic.Talcott WJ, Yu JB, Gross CP, Park HS. Social Connectedness Among Medicare Beneficiaries Following the Onset of the COVID-19 Pandemic. JAMA Internal Medicine 2021, 181: 1245-1248. PMID: 34047760, PMCID: PMC8424484, DOI: 10.1001/jamainternmed.2021.2348.
• Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ.Talcott WJ, Miccio JA, Park HS, White AA, Kozono DE, Singer L, Sands JM, Sholl LM, Detterbeck FC, Mak RH, Decker RH, Kann BH. Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ. Lung Cancer (Amsterdam, Netherlands) 2021, 157: 17-20. PMID: 34052704, DOI: 10.1016/j.lungcan.2021.05.028.
• Pan-cancer analysis of prognostic metastatic phenotypes.Zaorsky NG, Wang X, Garrett SM, Lehrer EJ, Lin C, DeGraff DJ, Spratt DE, Trifiletti DM, Kishan AU, Showalter TN, Park HS, Yang JT, Chinchilli VM, Wang M. Pan-cancer analysis of prognostic metastatic phenotypes. International Journal Of Cancer. Journal International Du Cancer 2022, 150: 132-141. PMID: 34287840, PMCID: PMC8595638, DOI: 10.1002/ijc.33744.
• Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials.Metzger AL, Kusi Appiah A, Wright CM, Jairam V, Amini A, Park HS, Welsh JW, Thomas CR, Verma V, Ludmir EB. Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials. International Journal Of Cancer. Journal International Du Cancer 2021, 149: 1683-1690. PMID: 34173669, DOI: 10.1002/ijc.33719.
• Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy.Li JY, Park HS, Huang GS, Young MR, Ratner E, Santin A, Damast S. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy. Gynecologic Oncology 2021, 163: 557-562. PMID: 34602287, DOI: 10.1016/j.ygyno.2021.09.018.
• Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques.Jairam V, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques. Lung Cancer (Amsterdam, Netherlands) 2021, 161: 171-179. PMID: 34607209, DOI: 10.1016/j.lungcan.2021.09.010.
• Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management.Leapman MS, Wang R, Park HS, Yu JB, Sprenkle PC, Dinan MA, Ma X, Gross CP. Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management. JAMA Network Open 2021, 4: e2128646. PMID: 34623406, PMCID: PMC8501394, DOI: 10.1001/jamanetworkopen.2021.28646.
• Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States.Mattes MD, Suneja G, Haffty BG, Takita C, Katz MS, Ohri N, Deville C, Siker ML, Park HS. Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States. Advances In Radiation Oncology 2021, 6: 100802. PMID: 34693080, PMCID: PMC8515237, DOI: 10.1016/j.adro.2021.100802.
• Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial.Liu Y, Cheng Y, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X, Hamaji M, Park HS. Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial. Translational Lung Cancer Research 2021, 10: 3793-3806. PMID: 34733629, PMCID: PMC8512470, DOI: 10.21037/tlcr-21-632.
• Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.Leapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening. JAMA Oncology 2022, 8: 41-47. PMID: 34762100, PMCID: PMC8587214, DOI: 10.1001/jamaoncol.2021.5143.
• Emergency Department Visits for Radiation Cystitis Among Patients with a Prostate Cancer History.Lee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency Department Visits for Radiation Cystitis Among Patients with a Prostate Cancer History. BJU International 2021 PMID: 34806813, DOI: 10.1111/bju.15650.
• Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy.Raju SC, Peters GW, Decker RH, Park HS. Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy. Practical Radiation Oncology 2022, 12: e110-e116. PMID: 34861443, DOI: 10.1016/j.prro.2021.11.006.
• Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.Haque W, Singh A, Park HS, Teh BS, Butler EB, Zeng M, Lin SH, Welsh JW, Chang JY, Verma V. Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer. Acta Oncologica (Stockholm, Sweden) 2022, 61: 403-408. PMID: 34913815, DOI: 10.1080/0284186X.2021.2012253.
• A reply to "Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC".Jairam V, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. A reply to "Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC". Lung Cancer (Amsterdam, Netherlands) 2022, 168: 84-85. PMID: 34933760, DOI: 10.1016/j.lungcan.2021.12.003.
• Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control.Johung KL, Park HS. Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control. International Journal Of Radiation Oncology, Biology, Physics 2022, 112: 585. PMID: 35101192, DOI: 10.1016/j.ijrobp.2021.07.1707.
• Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review.Hayman TJ, Bhatia AK, Jethwa KR, Young MR, Park HS. Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review. Translational Cancer Research 2021, 10: 2571-2585. PMID: 35116571, PMCID: PMC8798834, DOI: 10.21037/tcr-20-2096.
• Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer.Saeed NA, Jin L, Sasse AW, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, Park HS. Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer. Journal Of Thoracic Disease 2022, 14: 306-320. PMID: 35280466, PMCID: PMC8902118, DOI: 10.21037/jtd-21-1566.
• Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series.Diamond BH, Verma N, Shukla UC, Park HS, Koffer PP. Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series. Advances In Radiation Oncology 2022, 7: 100883. PMID: 35387416, PMCID: PMC8977911, DOI: 10.1016/j.adro.2021.100883.
• Nonadherence to Multimodality Cancer Treatment Guidelines in the United States.Tchelebi LT, Shen B, Wang M, Potters L, Herman J, Boffa D, Segel JE, Park HS, Zaorsky NG. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States. Advances In Radiation Oncology 2022, 7: 100938. PMID: 35469182, PMCID: PMC9034283, DOI: 10.1016/j.adro.2022.100938.
• Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy.Jairam V, Park HS, Yu JB, Bindra RS, Contessa JN, Jethwa KR. Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy. Advances In Radiation Oncology 2022, 7: 100949. PMID: 35521071, PMCID: PMC9065721, DOI: 10.1016/j.adro.2022.100949.